CASI Pharmaceuticals Inc CASI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
2.45quote price arrow down-0.01 (-0.20%)
Volume
15,069
Close
2.46quote price arrow down-0.03 (-1.20%)
Volume
273,146
52 week range
1.15 - 3.90

...

Loading . . .

KEY STATS

  • Open2.54
  • Day High2.54
  • Day Low2.42
  • Prev Close2.49
  • 52 Week High3.90
  • 52 Week High Date01/26/21
  • 52 Week Low1.15
  • 52 Week Low Date03/12/20
  • Market Cap304.89M
  • Shares Out123.94M
  • 10 Day Average Volume0.49M
  • Dividend-
  • Dividend Yield-
  • Beta0.37
  • 1 Year % Change17.7

RATIOS/PROFITABILITY

  • EPS (TTM)-0.45
  • P/E (TTM)-5.42
  • Fwd P/E (NTM)-8.48
  • EBITDA (MRQ)-32.457M
  • ROE (MRQ)-54.67%
  • Revenue (MRQ)11.66M
  • Gross Margin (MRQ)24.18%
  • Net Margin (MRQ)-392.43%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/15/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest CASI Pharmaceuticals Inc News

There is no recent news for this security.

Latest CASI News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of therapeutics for cancer and other medical needs. It operates through the development of targeted therapeutics for the treatment of cancer segment. Its product pipeline includes internal development of its lead drug candidate, ENMD-2076; MARQIBO, ZEVALIN and EVOMELA, and early-stage candidates in preclinical development. Its ENMD-2076 is an...
Wei-Wu He Ph.D.
Chairman
Wei Zhang
President
Weihao Xu
Chief Financial Officer
Address
9620 Medical Center Dr Ste 300
Rockville, MD
20850-3396
United States